VFA
ADMA icon

Virtus Fund Advisers’s ADMA Biologics ADMA Stock Holding History

Virtus Fund Advisers’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$51.8K Sell
3,021
-7,457
-71% -$140K 0.16% 64
2024
Q3 		$209K Sell
10,478
-3,580
-25% -$55.7K 0.85% 9
2024
Q2 		$157K Buy
14,058
+713
+5% +$5.98K 0.62% 12
2024
Q1 		$88.1K Buy
13,345
+1,117
+9% +$6.11K 0.31% 35
2023
Q4 		$55.3K Hold
12,228
– – 0.34% 48
2023
Q3 		$43.8K Buy
12,228
+2,103
+21% +$8.09K 0.31% 56
2023
Q2 		$37.4K Buy
+10,125
New +$37.5K 0.26% 67

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Virtus Fund Advisers's ADMA Position: Q4 2024 in Review

Virtus Fund Advisers reduced its ADMA Biologics (ADMA) stake by 71% in Q4 2024, selling an estimated $140K and leaving 3,021 shares worth $51.8K. The position accounts for 0.16% of the portfolio, ranked #64.

Virtus Fund Advisers first reported a position in ADMA in Q2 2023 and has held it in 7 quarters since. The position peaked at $209K in Q3 2024. 321 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Virtus Fund Advisers held 3,021 shares of ADMA Biologics worth $51.8K as of Q4 2024.
  • Virtus Fund Advisers sold 7,457 ADMA Biologics shares in Q4 2024, an estimated $140K.
  • ADMA Biologics made up 0.16% of Virtus Fund Advisers's portfolio in Q4 2024, its #64 holding.
  • Virtus Fund Advisers first reported a position in ADMA Biologics in Q2 2023 and has held it in 7 quarters since.
  • Virtus Fund Advisers's ADMA Biologics position peaked at $209K in Q3 2024.
  • 321 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.